Letter obtained by CNN shows FDA defended new monkeypox vaccine strategy to vaccine maker

Letter obtained by CNN shows FDA defended new monkeypox vaccine strategy to vaccine maker

The US Food and Drug Administration defended the federal government's recent decision to stretch out its limited supply of the Jynneos monkeypox vaccine by giving individuals smaller doses using a

Letter obtained by CNN shows FDA defended new monkeypox vaccine strategy to vaccine maker

(CNN) — The US Food and Drug Administration defended the federal government’s recent decision to stretch out its limited supply of the Jynneos monkeypox vaccine by giving...

Letter obtained by CNN shows FDA defended new monkeypox vaccine strategy to vaccine maker

By MJ Lee, CNN White House correspondentThe US Food and Drug Administration defended the federal government’s recent decision to stretch out its limited supply of the Jynneos monkeypox vaccine by giving individuals smaller doses using a different method of injection, pointing out in a letter to the company that manufactures the vaccine that a 2015 clinical study showed “a very similar immune response” to the new method as well as the previously …

Letter obtained by CNN shows FDA defended new monkeypox vaccine strategy to vaccine maker

By MJ Lee, CNN White House correspondent The US Food and Drug Administration defended the federal government’s recent decision to stretch out its limited supply of the Jynneos monkeypox vaccine by giving individuals smaller doses using a different method of injection, pointing out in a letter to the company that manufactures the vaccine that a

Letter obtained by CNN shows FDA defended new monkeypox vaccine strategy to vaccine maker - Local News 8

By MJ Lee, CNN White House correspondent The US Food and Drug Administration defended the federal government’s recent decision to stretch out its limited supply of the Jynneos monkeypox vaccine by giving individuals smaller doses using a different method of injection, pointing out in a letter to the company that manufactures the vaccine that a

Letter obtained by CNN shows FDA defended new monkeypox vaccine strategy to vaccine maker

The US Food and Drug Administration defended the federal government's recent decision to stretch out its limited supply of the Jynneos monkeypox vaccine by giving individuals smaller doses using a different method of injection, pointing out in a letter to the company that manufactures the vaccine that a 2015 clinical study showed "a very similar immune response" to the new method as well as the previously used one.